TotalMarketCap

Erasca

ERASNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.640 B

$13.27 -11.03%

Close of 6 Nov 2026

As of 6 Nov 2026, Erasca (ERAS) has a market capitalization of $4.64B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$124.5M

Loss-making

Shares outstanding

349,762,035

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #55Travere TherapeuticsTVTX$4.70B
  2. #56Dianthus TherapeuticsDNTH$4.69B
  3. #57ErascaERAS$4.64B
  4. #58Legend BiotechLEGN$4.39B
  5. #59Edgewise TherapeuticsEWTX$4.26B

What if Erasca were worth as much as…

Open the what-if tool →

Gold $28.2T

$80,731.67

Per share 6,086× higher

Bitcoin $1.53T

$4,368.25

Per share 329× higher

Apple $5.02T

$14,340.56

Per share 1,081× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Erasca are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.